Long’s Drugs - Ownership and Business Overview

Life ScienceCompany

Long’s Drugs Ownership

Who owns Long’s Drugs?

Long’s Drugs is owned by Avita Pharmacy. It was acquired on December 4, 2019.

Was Long’s Drugs formerly PE-backed?

Yes. Long’s Drugs was formerly owned by 1 private investor.

Long’s Drugs Business Overview

Where is Long’s Drugs headquartered?

Long’s Drugs is headquartered in Sarasota, Florida.

What sector is Long’s Drugs in?

Long’s Drugs is a life science company.

When was Long’s Drugs founded?

Long’s Drugs was founded in 1968.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 253 acquisitions of life science companies in 2019, including 46 acquisitions by private equity firms, and 207 by strategics.

Long’s Drugs, Inc.

6230 University Parkway, Suite 301,
Sarasota, Florida 33240
United States,
(941) 480-1720
www.longsrx.com

Long’s Drugs, Inc. is an independent specialty pharmacy in the Southeast, with locations in South Carolina, North Carolina, Georgia, Louisiana, and Texas. Longs have expanded its retail footprint to grow a comprehensive specialty pharmacy business that serves patients with chronic illnesses and complex medical conditions such as HIV/AIDS. In addition, Longs has worked to develop relationships with mental health and long-term care facilities in its current geographies, creating additional lines of business and new avenues for the company to provide pharmacy services.


 Subscribe to unlock this and 209,632
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.